tiprankstipranks
Trending News
More News >
CSPC Pharmaceutical Group Limited (CHJTF)
OTHER OTC:CHJTF
US Market
Advertisement

CSPC Pharmaceutical Group (CHJTF) Ratios

Compare
25 Followers

CSPC Pharmaceutical Group Ratios

CHJTF's free cash flow for Q4 2024 was ¥0.68. For the 2024 fiscal year, CHJTF's free cash flow was decreased by ¥ and operating cash flow was ¥0.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.24 2.63 2.67 2.81 2.53
Quick Ratio
1.95 2.32 2.39 2.47 2.23
Cash Ratio
0.75 1.18 1.15 1.28 1.16
Solvency Ratio
0.54 0.62 0.66 0.71 0.76
Operating Cash Flow Ratio
0.47 0.41 0.92 0.66 1.03
Short-Term Operating Cash Flow Coverage
19.13 9.28 27.80 0.00 28.92
Net Current Asset Value
¥ 11.47B¥ 15.48B¥ 13.90B¥ 15.50B¥ 10.92B
Leverage Ratios
Debt-to-Assets Ratio
0.01 0.02 0.01 <0.01 0.01
Debt-to-Equity Ratio
0.01 0.02 0.02 <0.01 0.01
Debt-to-Capital Ratio
0.01 0.02 0.02 <0.01 0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 <0.01 0.00 <0.01
Financial Leverage Ratio
1.38 1.39 1.38 1.34 1.35
Debt Service Coverage Ratio
25.55 15.16 19.64 852.96 24.29
Interest Coverage Ratio
0.00 296.58 272.69 814.87 444.25
Debt to Market Cap
<0.01 <0.01 <0.01 0.00 <0.01
Interest Debt Per Share
0.04 0.06 0.05 0.01 0.03
Net Debt to EBITDA
-0.93 -1.33 -1.26 -1.21 -1.02
Profitability Margins
Gross Profit Margin
69.97%70.51%71.94%75.84%74.91%
EBIT Margin
18.50%21.43%24.08%24.52%25.62%
EBITDA Margin
24.76%24.66%24.06%27.62%28.85%
Operating Profit Margin
18.50%22.20%21.94%22.41%21.79%
Pretax Profit Margin
19.23%21.36%24.56%24.49%25.57%
Net Profit Margin
14.92%16.98%16.93%16.69%18.41%
Continuous Operations Profit Margin
14.96%17.55%19.73%16.94%20.91%
Net Income Per EBT
77.58%79.48%68.94%68.15%72.00%
EBT Per EBIT
103.96%96.21%111.94%109.28%117.36%
Return on Assets (ROA)
10.01%12.69%12.99%13.19%14.47%
Return on Equity (ROE)
14.06%17.69%17.97%17.63%19.49%
Return on Capital Employed (ROCE)
15.91%21.27%21.43%22.36%21.67%
Return on Invested Capital (ROIC)
12.26%17.20%17.39%18.54%17.48%
Return on Tangible Assets
10.68%13.39%13.77%13.49%14.87%
Earnings Yield
4.37%7.52%6.20%5.54%5.44%
Efficiency Ratios
Receivables Turnover
3.27 3.24 4.72 4.21 4.85
Payables Turnover
4.05 3.59 5.02 5.00 5.66
Inventory Turnover
3.23 3.25 3.52 2.67 3.19
Fixed Asset Turnover
2.26 2.97 2.92 2.87 2.65
Asset Turnover
0.67 0.75 0.77 0.79 0.79
Working Capital Turnover Ratio
2.49 2.06 2.05 2.45 2.84
Cash Conversion Cycle
134.58 123.34 108.38 150.28 125.43
Days of Sales Outstanding
111.61 112.71 77.35 86.78 75.33
Days of Inventory Outstanding
113.05 112.29 103.72 136.50 114.55
Days of Payables Outstanding
90.09 101.67 72.68 73.00 64.46
Operating Cycle
224.66 225.00 181.07 223.28 189.89
Cash Flow Ratios
Operating Cash Flow Per Share
0.40 0.35 0.68 0.49 0.64
Free Cash Flow Per Share
0.00 0.19 0.45 0.31 0.49
CapEx Per Share
0.00 0.16 0.23 0.18 0.15
Free Cash Flow to Operating Cash Flow
0.00 0.55 0.66 0.64 0.77
Dividend Paid and CapEx Coverage Ratio
1.40 0.90 1.65 1.41 2.20
Capital Expenditure Coverage Ratio
0.00 2.21 2.91 2.77 4.34
Operating Cash Flow Coverage Ratio
9.56 5.91 14.10 50.96 20.44
Operating Cash Flow to Sales Ratio
0.15 0.12 0.26 0.17 0.27
Free Cash Flow Yield
0.00%2.93%6.17%3.70%6.23%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
22.23 13.30 16.13 18.06 18.37
Price-to-Sales (P/S) Ratio
3.23 2.26 2.73 3.01 3.38
Price-to-Book (P/B) Ratio
3.08 2.35 2.90 3.18 3.58
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 34.17 16.22 27.05 16.05
Price-to-Operating Cash Flow Ratio
21.63 18.69 10.65 17.27 12.35
Price-to-Earnings Growth (PEG) Ratio
-0.58 -2.30 -1.77 1.11 0.46
Price-to-Fair Value
3.08 2.35 2.90 3.18 3.58
Enterprise Value Multiple
12.11 7.83 10.09 9.70 10.70
Enterprise Value
95.48B 66.79B 76.71B 90.00B 86.52B
EV to EBITDA
12.49 7.83 10.09 9.70 10.70
EV to Sales
3.09 1.93 2.43 2.68 3.09
EV to Free Cash Flow
0.00 29.22 14.42 24.04 14.65
EV to Operating Cash Flow
20.17 15.98 9.47 15.35 11.27
Tangible Book Value Per Share
2.72 2.74 2.44 2.69 2.24
Shareholders’ Equity Per Share
2.83 2.80 2.50 2.66 2.21
Tax and Other Ratios
Effective Tax Rate
0.22 0.18 0.18 0.17 0.18
Revenue Per Share
2.63 2.91 2.65 2.81 2.34
Net Income Per Share
0.39 0.49 0.45 0.47 0.43
Tax Burden
0.78 0.79 0.69 0.68 0.72
Interest Burden
1.04 1.00 1.02 1.00 1.00
Research & Development to Revenue
0.18 0.15 0.13 0.12 0.12
SG&A to Revenue
0.04 0.04 0.03 0.03 0.03
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.07 0.57 1.30 0.87 1.32
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis